2023年5月2日

使临床有效性通过完全的互操作性和集成数字病理解决方案2023年4月27日籼稻实验室和Lunit,宣布了一项协议,提供完全籼稻实验室之间的互操作解决方案光环美联社®映像管理软件平台和AI病理学的Lunit套件产品。合并后的解决方案已经在使用Guardant健康,一家领先的精密肿瘤学的公司。“利用数字病理和人工智能的力量来改善组织的研究和病人护理的核心是我们的使命,”史蒂文Hashagen说,籼稻实验室的创始人兼首席执行官。“这有价值的合作使我们能够无缝集成Lunit AI的病理学的解决方案,包括Lunit PD-L1范围为非小细胞肺癌(NSCLC)光环,我们CE-IVD注册临床影像管理平台”。Brandon Suh, CEO of Lunit said, "The partnership with Indica Labs, a market leader in digital pathology, with interoperable workflow integration, will enable pathologists and labs to deliver faster, more accurate, and more reproducible answers using Lunit’s AI solutions." Lunit SCOPE PD-L1 NSCLC is a CE-marked AI solution for detecting and analyzing PD-L1 TPS, a cancer biomarker. The solution may assist pathologists by minimizing interpretation variability and allowing better prediction of treatment outcomes for NSCLC patients, as demonstrated in study findings published in the European Journal of Cancer. Indica Labs developed the HALO AP platform specifically to meet the needs of anatomic pathology labs worldwide. The CE-IVD certified HALO AP platform supports a wide range of tissue-based workflows, including primary diagnosis, secondary consults, clinical trials, synoptic reporting, quantitative analytics and AI. One of the key advantages of HALO AP is the seamless integration of AI solutions into the workflow, whether developed by Indica Labs or third parties. To simplify integration, a HALO AP software development kit (SDK) is available to all algorithm developers. With HALO AP, users can utilize algorithms in an automated, stepwise workflow that can be locked, secured and audited to prevent tampering or misuse. Lunit SCOPE PD-L1 NSCLC can be activated in the HALO AP user interface. Analysis progress, all results and visual markup images can be reviewed in HALO AP, so users never have to leave the viewer or shift between systems. With HALO AP’s built-in workflow management tools, an algorithm can automatically run upon slide intake so that the results are ready for the pathologist to review the case. By integrating Lunit’s powerful AI solutions into HALO AP, pathologists and researchers can benefit from the combined capabilities of both platforms, providing them with advanced tools to help them make more informed decisions.